EUVIMEDEUVIMED entdecken
Crossref

A Neovascularization and EGFR Dual‐Targeting Gold Nanotheranostic System for Non‐Small Cell Lung Cancer Treatment

Zhitao Zhu, Zhengzhong Lv, Yurong Fan, Hongyuan Wen, Yuqi Zhang, Yirui Guo, Miao Li, Xingxiang Ren, Haibin Shi iD, Guohua Fan

Advanced Healthcare Materials · 2025-08 · 14 (21)

DOI: 10.1002/adhm.202500854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 11.06.2025. Verfasst von Zhitao Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Gold, Lung Neoplasms, Metal Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic Research Program of Jiangsu, Suzhou Fundamental Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐small cell lung cancer (NSCLC) is a cancer with high morbidity and mortality and faces multiple clinical challenges in early diagnosis, efficient treatment, targeted drug selection, and drug resistance. Herein, neovascularization and EGFR dual‐targeting gold nanotheranostic system Bev‐Au‐CD(Osi) is designed and fabricated for epidermal growth factor receptror (EGFR)‐mutated NSCLC treatment. This nanosystem consists of gold nanoparticle as drug nanocarrier and imaging contrast agent, Bevacizumab for targeting tumor neovascularization, and β‐cyclodextrin (β‐CD) as the cage for encapsulating EGFR mutant inhibitor Osimertinib. Taking advantage of the specific targeting ability of Bevacizumab to vascular endothelial growth factor (VEGF), Bev‐Au‐CD(Osi) nanoparticles target and accumulate at the tumor site for sensitive computed tomography (CT)/photoacoustic (PA) imaging of tumors. More notably, the sustained release of Osimertinib efficiently suppresses tumor growth through inhibiting angiogenesis and blocking the EGFR signaling pathway, significantly enhancing the therapeutic efficacy of NSCLC tumor in living mice. This work provides a powerful and universal nanotheranostic system for the precise treatment of EGFR‐mutated NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGoldLung NeoplasmsMetal NanoparticlesTheranostic NanomedicineNeovascularization, PathologicAnimalsErbB ReceptorsHumansMiceAniline CompoundsAcrylamidesCell Line, TumorBevacizumabbeta-CyclodextrinsMice, NudeMice, Inbred BALB CIndolesPyrimidines

Stichwörter der Autor:innen

CT imaginggold nanoparticlesnon‐small cell lung cancertheranosticstumor targeted therapy

Substanzen

GoldErbB ReceptorsAniline CompoundsosimertinibAcrylamidesBevacizumabEGFR protein, humanbeta-CyclodextrinsbetadexIndoles

Autor:innen und Institutionen

  • Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
  • Department of Radiology, The Second People's Hospital of Lianyungang, Lianyungang, 222023, China.
  • State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow Universi…

ORCID-Profile: Haibin Shi

Förderung

  • National Natural Science Foundation of China
  • Basic Research Program of Jiangsu
  • Suzhou Fundamental Research Project
  • Science and Technology of Shanxi Province
  • Open Project Program of the State Key Laboratory of Radiation Medicine and Protection
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Zhu, Z., Lv, Z., Fan, Y., Wen, H., Zhang, Y., Guo, Y., Li, M., Ren, X., Shi, H., & Fan, G. (2025). A Neovascularization and EGFR Dual‐Targeting Gold Nanotheranostic System for Non‐Small Cell Lung Cancer Treatment. Advanced Healthcare Materials, 14(21). https://doi.org/10.1002/adhm.202500854

Vancouver

Zhu Z, Lv Z, Fan Y, Wen H, Zhang Y, Guo Y, et al. A Neovascularization and EGFR Dual‐Targeting Gold Nanotheranostic System for Non‐Small Cell Lung Cancer Treatment. Advanced Healthcare Materials. 2025;14(21). doi:10.1002/adhm.202500854

BibTeX
@article{Zhu2025,
  author = {Zhu, Zhitao and Lv, Zhengzhong and Fan, Yurong and Wen, Hongyuan and Zhang, Yuqi and Guo, Yirui and Li, Miao and Ren, Xingxiang and Shi, Haibin and Fan, Guohua},
  title = {A Neovascularization and EGFR Dual‐Targeting Gold Nanotheranostic System for Non‐Small Cell Lung Cancer Treatment},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {21},
  doi = {10.1002/adhm.202500854}
}
Kostenlos starten →